NMR Biomed. 2006 Oct;19(6):669-80.

MRI for development of disease-modifying osteoarthritis drugs.

Source

Department of Radiology, Beth Israel Deaconess Medical Center, 4 Blackfan Circle, Boston, MA 02115, USA. dburstei@bidmc.harvard.edu

Abstract

MRI has advantages as an imaging modality for drug development through its potential to provide information regarding localized morphological parameters, in addition to metrics of the structural and molecular state of cartilage. These metrics have the potential to provide earlier indications of pathology and may progress more rapidly than radiographic measures. These combined scans of localized morphology and matrix parameters will most likely provide a fuller assessment of cartilage state and will improve the cost and practicality of an overall evaluation of cartilage status by MRI. In the first part of this review, the relevant parameters are presented in terms of the information content they might provide in the drug development process. In the second part, applications of the MRI parameters in preclinical and clinical drug development are presented.

PMID:: 16986116; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms

Publication Types

Review

MeSH Terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Education

New England Research Institutes Inc.

Medical

Libraries

LinkOut Holdings

Supplemental Content

Save items

Related citations in PubMed

Review Clinical, biochemical and imaging methods of assessing osteoarthritis and clinical trials with agents claiming 'chondromodulating' activity. [Osteoarthritis Cartilage. 1994]
Review Clinical, biochemical and imaging methods of assessing osteoarthritis and clinical trials with agents claiming 'chondromodulating' activity.
Theiler R, Ghosh P, Brooks P. Osteoarthritis Cartilage. 1994 Mar; 2(1):1-23.
Summary and recommendations of the OARSI FDA osteoarthritis Assessment of Structural Change Working Group. [Osteoarthritis Cartilage. 2011]
Summary and recommendations of the OARSI FDA osteoarthritis Assessment of Structural Change Working Group.
Conaghan PG, Hunter DJ, Maillefert JF, Reichmann WM, Losina E. Osteoarthritis Cartilage. 2011 May; 19(5):606-10. Epub 2011 Mar 23.
Review MR in oncology drug development. [NMR Biomed. 2006]
Review MR in oncology drug development.
Galbraith SM. NMR Biomed. 2006 Oct; 19(6):681-9.
Review State-of-the-art disease-modifying osteoarthritis drugs. [Curr Rheumatol Rep. 2005]
Review State-of-the-art disease-modifying osteoarthritis drugs.
Moskowitz RW, Hooper M. Curr Rheumatol Rep. 2005 Mar; 7(1):15-21.
Review From anatomy to the target: contributions of magnetic resonance imaging to preclinical pharmaceutical research. [Anat Rec. 2001]
Review From anatomy to the target: contributions of magnetic resonance imaging to preclinical pharmaceutical research.
Beckmann N, Mueggler T, Allegrini PR, Laurent D, Rudin M. Anat Rec. 2001 Apr; 265(2):85-100.

See reviews... See all...

Cited by 3 PubMed Central articles

Translational biomarkers: from preclinical to clinical a report of 2009 AAPS/ACCP Biomarker Workshop. [AAPS J. 2011]
Translational biomarkers: from preclinical to clinical a report of 2009 AAPS/ACCP Biomarker Workshop.
Bai JP, Bell R, Buckman S, Burckart GJ, Eichler HG, Fang KC, Goodsaid FM, Jusko WJ, Lesko LL, Meibohm B, et al. AAPS J. 2011 Jun; 13(2):274-83. Epub 2011 Mar 30.
Review Recent advances in MRI of articular cartilage. [AJR Am J Roentgenol. 2009]
Review Recent advances in MRI of articular cartilage.
Gold GE, Chen CA, Koo S, Hargreaves BA, Bangerter NK. AJR Am J Roentgenol. 2009 Sep; 193(3):628-38.
Review A review of imaging techniques for systems biology. [BMC Syst Biol. 2008]
Review A review of imaging techniques for systems biology.
Kherlopian AR, Song T, Duan Q, Neimark MA, Po MJ, Gohagan JK, Laine AF. BMC Syst Biol. 2008 Aug 12; 2:74. Epub 2008 Aug 12.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

MRI for development of disease-modifying osteoarthritis drugs.
MRI for development of disease-modifying osteoarthritis drugs.
NMR Biomed. 2006 Oct ;19(6):669-80.

PubMed
Peptide QSAR on substance P analogues, enkephalins and bradykinins containing L-...
Peptide QSAR on substance P analogues, enkephalins and bradykinins containing L- and D-amino acids.
Acta Chem Scand. 1990 Jan ;44(1):50-5.

PubMed
Robustness analysis of biochemical network models.
Robustness analysis of biochemical network models.
Syst Biol (Stevenage). 2006 May ;153(3):96-104.

PubMed
CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding prote...
CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein.
Science. 1990 Sep 21 ;249(4975):1431-3.

PubMed
Breast cancer treatment of older women in integrated health care settings.
Breast cancer treatment of older women in integrated health care settings.
J Clin Oncol. 2006 Sep 20 ;24(27):4377-83.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: